Chronic Hepatitis C Treatment for Genotype 2 or 3 in Brazil: Cost Effectiveness Analysis of Peginterferon Plus Ribavirin As First Choice Treatment . Braz. J. Pharm. Sci. 2014, 50 (2), 345-352. https://doi.org/10.1590/S1984-82502014000200014.